16 min listen
2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS
2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS
ratings:
Length:
11 minutes
Released:
Oct 19, 2016
Format:
Podcast episode
Description
In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12.
Listen to the podcast to hear Dr. Weiss explain:
what DCIS is
why postmenopausal women should be reassured no matter which of these medicines they’re taking
the side effects of each medicine
Listen to the podcast to hear Dr. Weiss explain:
what DCIS is
why postmenopausal women should be reassured no matter which of these medicines they’re taking
the side effects of each medicine
Released:
Oct 19, 2016
Format:
Podcast episode
Titles in the series (100)
2014 San Antonio Breast Cancer Symposium Research Highlights: Brian Wojciechowski, M.D. discusses research presented at the 2014 San Antonio Breast Cancer Symposium by Breastcancer.org Podcast